Quinazoline derivatives as medicaments
    5.
    发明申请
    Quinazoline derivatives as medicaments 有权
    喹唑啉衍生物作为药物

    公开(公告)号:US20050096333A1

    公开(公告)日:2005-05-05

    申请号:US10957183

    申请日:2004-09-30

    摘要: Quinazoline derivatives have the formula: or the pharmaceutically acceptable salts thereof; wherein each of Z5, Z6, Z7 and Z8 is N or CH and wherein one or two Z5, Z6, Z7 and Z8 are N and wherein two adjacent Z positions cannot be N; wherein m and n are each independently 0-3; wherein R1 is independently OH, SH, NH2, OR, SR, NHR, halo or R-halide; wherein two adjacent R1 groups may be joined to form an aliphatic hetero cycle ring of 5-6 members; wherein R2 is independently R, halo, R-halide, OR-halide, NH2, CONH2 or CONHR; wherein R is optionally substituted C1-C12 alkyl, C1-C12 alkenyl, C1-C12 alkynyl, or aryl C1-C12 alkyl, containing 0-4 heteroatoms in place of a carbon in the carbon backbone, where the optional substituents are ═O, ═N, or OH; and wherein R3 is H or CH3. Such compounds are useful in pharmaceutical compositions and methods of treating conditions characterized by enhanced TGFβ activity.

    摘要翻译: 喹唑啉衍生物具有下式:或其药学上可接受的盐; 其中Z 5,Z 6,Z 7和Z 8各自为N或CH,其中一个或多个 两个Z 5,Z 6,Z 7和Z 8是N,并且其中两个相邻的Z位置不能是 N; 其中m和n各自独立地为0-3; 其中R 1独立地是OH,SH,NH 2,OR,SR,NHR,卤素或R卤化物; 其中两个相邻的R 1个基团可以连接形成5-6个成员的脂肪族杂环; 其中R 2独立地是R 1,R 2,R 2卤素,OR-卤素,NH 2,CONH 2或CONHR; 其中R是任选取代的C 1 -C 12烷基,C 1 -C 12 - 烯基,C

    Quinazoline derivatives as medicaments
    6.
    发明授权
    Quinazoline derivatives as medicaments 有权
    喹唑啉衍生物作为药物

    公开(公告)号:US07232824B2

    公开(公告)日:2007-06-19

    申请号:US10957183

    申请日:2004-09-30

    IPC分类号: C07D239/94 C07D471/04

    摘要: Quinazoline derivatives have the formula: or the pharmaceutically acceptable salts thereof; wherein each of Z5, Z6, Z7 and Z8 is N or CH and wherein one or two Z5, Z6, Z7 and Z8 are N and wherein two adjacent Z positions cannot be N; wherein m and n are each independently 0–3; wherein R1 is independently OH, SH, NH2, OR, SR, NHR, halo or R-halide; wherein two adjacent R1 groups may be joined to form an aliphatic hetero cycle ring of 5–6 members; wherein R2 is independently R, halo, R-halide, OR-halide, NH2, CONH2 or CONHR; wherein R is optionally substituted C1–C12 alkyl, C1–C12 alkenyl, C1–C12 alkynyl, or aryl C1–C12 alkyl, containing 0–4 heteroatoms in place of a carbon in the carbon backbone, where the optional substituents are ═O, ═N, or OH; and wherein R3 is H or CH3. Such compounds are useful in pharmaceutical compositions and methods of treating conditions characterized by enhanced TGFβ activity.

    摘要翻译: 喹唑啉衍生物具有下式:或其药学上可接受的盐; 其中Z 5,Z 6,Z 7和Z 8各自为N或CH,并且其中一个或多个 两个Z 5,Z 6,Z 7和Z 8是N,并且其中两个相邻的Z位置不能是 N; 其中m和n各自独立地为0-3; 其中R 1独立地是OH,SH,NH 2,OR,SR,NHR,卤素或R卤化物; 其中两个相邻的R 1个基团可以连接形成5-6个成员的脂肪族杂环; 其中R 2独立地是R 1,R 2,R 2卤素,OR-卤素,NH 2,CONH 2或CONHR; 其中R是任选取代的C 1 -C 12烷基,C 1 -C 12 - 烯基,C